Institutional members access full text with Ovid®

Share this article on:

Current research in otosclerosis

Stankovic, Konstantina M; McKenna, Michael J

Current Opinion in Otolaryngology & Head and Neck Surgery: October 2006 - Volume 14 - Issue 5 - p 347–351
doi: 10.1097/01.moo.0000244194.97301.19
Hearing science

Purpose of review The aim of this article is to summarize and put into historical perspective current advances in research in otosclerosis, a disorder of the human temporal bone with a hereditary predisposition that is among the most common causes of acquired hearing loss.

Recent findings Genetic studies have revealed that otosclerosis is heterogeneous, with evidence for defects in at least seven genes associated with six distinct chromosomal loci. Measurements of high levels of osteoprotegerin expression in the normal otic capsule and soft tissues of the cochlea provide the first molecular insight as to why the normal otic capsule remodels minimally, if at all. Osteoprotegerin knockout mice provide the best available animal model to date to study abnormal otic capsule remodeling that closely resembles otosclerosis. There is mounting evidence that the measles virus plays an important role in pathogenesis of otosclerosis although the mechanisms by which the virus results in otosclerosis remain unknown. Quantitative measures of angiogenesis can reliably distinguish between clinical and histological otosclerosis. Advances in the emerging field of osteoimmunology will likely impact and benefit from the research in otosclerosis.

Summary Insights into molecular mechanisms that inhibit extensive remodeling in the normal otic capsule, and understanding of how these mechanisms are dysregulated in otosclerosis will allow future design of rational treatment strategies for otosclerosis.

Department of Otolaryngology, Massachusetts Eye and Ear Infirmary and Department of Otology and Laryngology, Harvard Medical School, Boston, Massachusetts, USA

Correspondence to Michael J. McKenna, MD, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA 02114-3096, USA Tel: +1 617 573 3651; fax: +1 617 573 3939; e-mail:

Sponsorship: This work was supported by NIDCD Grant 5RO1 DC03401-06 (M.J.M.), Safford grant (K.M.S. and M.J.M.) and Patricia and Barry Yellen Young Investigators Award (K.M.S.).

© 2006 Lippincott Williams & Wilkins, Inc.